146 related articles for article (PubMed ID: 6856953)
1. Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline.
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):519-22. PubMed ID: 6856953
[TBL] [Abstract][Full Text] [Related]
2. Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):207-21. PubMed ID: 7244360
[TBL] [Abstract][Full Text] [Related]
3. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
4. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
Fuller RW; Wong CJ; Hemrick-Luecke SK
Life Sci; 1986 Feb; 38(5):409-12. PubMed ID: 3945167
[TBL] [Abstract][Full Text] [Related]
5. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro.
Panova NG; Axenova LN; Medvedev AE
Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of rat brain monoamine oxidase type A by 2-aminotetralin and tetrahydroisoquinoline analogues of dopamine.
Feenstra MG; van der Velden T; Dijkstra D; Hommes OR; Horn AS
Pharm Weekbl Sci; 1983 Aug; 5(4):131-3. PubMed ID: 6622205
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
Schraven E; Reibert R
Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
[TBL] [Abstract][Full Text] [Related]
8. Proceedings: Influence of MAO-inhibitors on the intestinal absorption of biogenic amines.
Huebers H; Huebers E; Huebers U; Rummel W
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R36. PubMed ID: 4276566
[No Abstract] [Full Text] [Related]
9. Inhibitors of phenylethanolamine-N-methyltransferase. 2. Comparison of nonaromatic analogs of phenylethanolamines, 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline (SKF-64139) and 2,3-dichloro-alpha-methylbenzylamine: effects on rat brain and adrenal catecholamine content and blood pressure.
Liang NY; Tessel RE; Grunewald GL; Borchardt RT
J Pharmacol Exp Ther; 1982 Nov; 223(2):382-7. PubMed ID: 7131293
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke.
Méndez-Alvarez E; Soto-Otero R; Sánchez-Sellero I; López-Rivadulla Lamas M
Life Sci; 1997; 60(19):1719-27. PubMed ID: 9129127
[TBL] [Abstract][Full Text] [Related]
11. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
Gal S; Zheng H; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
[TBL] [Abstract][Full Text] [Related]
12. Aromatization of 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline by rat liver microsomes.
Fong KL; Hwang BY
Drug Metab Dispos; 1984; 12(1):14-9. PubMed ID: 6141906
[TBL] [Abstract][Full Text] [Related]
13. Influence of harmaline on the ability of pargyline to alter catecholamine metabolism in rats.
Fuller RW; Hemrick-Luecke SK; Perry KW
Biochem Pharmacol; 1981 Jun; 30(11):1295-8. PubMed ID: 7271828
[No Abstract] [Full Text] [Related]
14. Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats.
Fuller RW; Hemrick SK
Life Sci; 1978 Mar; 22(12):1083-6. PubMed ID: 642716
[No Abstract] [Full Text] [Related]
15. In vivo intraneuronal MAO inhibition in rat brain SKF 64139, comparison to other potent PNMT inhibitors.
Mefford IN; Roth KA; Gilberg M; Barchas JD
Eur J Pharmacol; 1981 Mar; 70(3):345-53. PubMed ID: 7227455
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.
Heikkila RE; Cohen G
Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):539-47. PubMed ID: 4824828
[No Abstract] [Full Text] [Related]
17. Depletion of epinephrine in rat hypothalamus by Ro 4-1284: influence of pargyline and harmaline.
Fuller RW; Hemrick-Luecke SK
Brain Res Bull; 1980; 5(5):589-91. PubMed ID: 6903452
[TBL] [Abstract][Full Text] [Related]
18. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thyroid monoamineoxidase by thyroxine and some specific inhibitors.
Knopp J; Torda T
Endokrinologie; 1979; 73(3):356-8. PubMed ID: 499103
[TBL] [Abstract][Full Text] [Related]
20. [Selective inhibition by pargyline and phenelzine of oxidation of biogenic amines in vivo].
Romanova LA; Gorkin VZ
Farmakol Toksikol; 1969; 32(6):667-9. PubMed ID: 5381595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
